Bedia Cakmakoglu (B Cakmakoglu, Bedia Çakmakoğlu)

ResearcherID Scopus Author ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 4

Top Topics

Renal Cell Carcinoma

Coronary Artery Disease

Endoplasmic Reticulum Stress

Binding Protein

Top Venues

Medical oncology (Northwood, London, England)

Immunological investigations

Istanbul Universitesi

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Istanbul Universitesi Jul 15 1995

Turkey

Prof. Dr. :: Department of Molecular Medicine

Publications

Merve Nur Atas, Barış Ertuğrul, Elif Sinem Iplik, Bedia Cakmakoglu, Arzu Ergen
The inhibitory effect of betulinic acid on epithelial-mesenchymal transition pathway in renal cell carcinoma. Medical oncology (Northwood, London, England) 39 (11) (2022)
Levent Aydemir, Elif Sinem Iplik, Baris Ertugrul, Goksu Kasarci, Merve Nur Atas, Murat Ulusan, Arzu Ergen, Bedia Cakmakoglu
Levofloxacin might be safe to use for OSCC patients. Medical oncology (Northwood, London, England) 38 (8) (2021)
Goksu Kasarci, Baris Ertugrul, Elif Sinem Iplik, Bedia Cakmakoglu
The apoptotic efficacy of succinic acid on renal cancer cell lines. Medical oncology (Northwood, London, England) 38 (12) (2021)
Burcin Aydin Ozgur, Ender Coskunpinar, S Bilgic Gazioglu, Abdullah Yilmaz, Y Musteri Oltulu, Bedia Cakmakoglu, Gunnur Deniz, Ali Osman Gurol, M T Yilmaz
Effects of Complement Regulators and Chemokine Receptors in Type 2 Diabetes. Immunological investigations 50 (5) (2020)